文献速递瓣膜外科

美国二尖瓣修复术:单中心与多中心手术医生的风险调整结局比较

Mitral valve repair in the United States: Single-center versus multicenter surgeons' risk-adjusted outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-02-28

基于2011-2019年STS成人心脏手术数据库的二尖瓣修复记录,比较在多个中心执业(MC)与单中心执业(SC)手术医生的风险调整结局率。SC医生的风险调整主要并发症或死亡(MMM)低于MC医生(OR 1.170,P<.001),校正医生和中心手术量后仍持续(OR 1.141,P=.0155);MC医生在其主要中心的MMM低于次要中心(OR 1.269,P<.001),部分归因于中心手术量差异(OR 1.130,P=.098)。SC与MC医生间风险调整延长住院时间无差异,但存在区域差异。

要点

  • SC医生二尖瓣修复的风险调整MMM低于MC医生(OR 1.170,P<.001)。
  • 校正医生和中心手术量后,SC医生MMM优势仍存在(OR 1.141,P=.0155)。
  • MC医生主要中心MMM低于次要中心(OR 1.269,P<.001),部分归因于中心手术量差异。

核心结论

  • 与单中心执业医生相比,将手术医生的工作量重新分配到多个中心对其二尖瓣修复的风险调整结局率有统计学显著的负面影响。

研究设计与样本

  • 回顾性分析2011-2019年STS成人心脏手术数据库中的二尖瓣修复记录。
  • MC医生定义为一年内在≥2个中心实施二尖瓣修复手术,并识别每位MC医生手术量最大的主要中心。
  • 应用STS批准的2018年孤立二尖瓣修复风险模型,评估风险调整30天主要并发症或死亡(MMM)和风险调整延长住院时间(pLOS)。
  • 评估医生和医院二尖瓣修复量及总心脏手术量的影响。

主要发现

  • 与MC医生相比,SC医生的风险调整MMM更低(OR 1.170;P<.001)。
  • 校正医生和中心手术量后,该发现持续存在(OR 1.141;P=.0155)。
  • MC医生在其主要中心的风险调整MMM低于次要中心(OR 1.269;P<.001)。
  • 上述主要与次要中心的差异部分归因于中心手术量变异(OR 1.130;P=.098)。
  • SC与MC医生之间未发现风险调整pLOS差异,但区域风险调整pLOS差异持续存在。

关键数值与推荐

  • MMM定义包括手术死亡、透析、卒中、延长通气、纵隔炎或再次手术。
  • MC医生定义为一年内在≥2个中心实施二尖瓣修复手术。
  • 主要中心为每位MC医生二尖瓣修复手术量最大的中心。

临床怎么用

  • 对于在多个中心执业的心胸外科医生,应关注其非主要中心的二尖瓣修复风险调整结局可能较差。
  • 评估医生结局时需考虑执业中心数量及中心手术量差异对风险调整结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Health care consolidation may force cardiac surgeons to operate at multiple centers. Few data exist as to this phenomenon's effect upon patients' quality of care as measured by risk-adjusted outcome (RAO) rates. We sought to compare mitral valve repair (MVr) RAO rates between surgeons operating at multiple centers (MC) versus single-centers (SC); and for MC surgeons, to compare MVr RAO rates between their primary and secondary centers. METHODS: The 2011-2019 Society of Thoracic Surgeons Adult Cardiac Surgery Database's MVr records were analyzed. MC surgeons performed MVr procedures at ≥2 centers within a year; each MC surgeon's greatest MVr volume ("primary") center was identified. Applying the Society of Thoracic Surgeons-approved 2018 isolated-MVr risk models, study end points included risk-adjusted 30-day major morbidity or mortality (MMM; determined by operative death, dialysis, stroke, prolonged ventilation, mediastinitis, or repeat procedure) and risk-adjusted prolonged length of stay (pLOS). The impacts of surgeon's and hospital's MVr and total cardiac surgery volumes were evaluated. RESULTS: Compared with MC surgeons, SC surgeons had lower risk-adjusted MMM (odds ratio [OR], 1.170; P < .001). After adjusting for surgeon and center volumes, this finding persisted (OR, 1.141; P = .0155). MC surgeons experienced lower risk-adjusted MMM at their primary versus secondary centers (OR, 1.269; P < .001); this finding was partially attributable to center-based volume variations (OR, 1.130; P = .098). No SC versus MC surgeon risk-adjusted pLOS differences were found; however, regional risk-adjusted pLOS differences persisted. CONCLUSIONS: Compared with SC surgeons, reallocating surgeons' caseload across multiple centers has a statistically significant, negative impact on their MVr RAO rates.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bilfinger T, Bennett A, Bogue TA, et al. Mitral valve repair in the United States: Single-center versus multicenter surgeons' risk-adjusted outcomes. J Thorac Cardiovasc Surg. 2025. PMID: 40024519. doi:10.1016/j.jtcvs.2025.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。